GoodRx Holdings (GDRX) Deferred Taxes (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Deferred Taxes data on file, last reported at $4.1 million in Q1 2026.

• For the quarter ending Q1 2026, Deferred Taxes changed N/A year-over-year to $4.1 million; the trailing twelve-month figure through Mar 2026 stood at $4.8 million (up 140.11% YoY), and the FY2025 full-year result was $20.1 million, up 268.47% from the prior year.
• Deferred Taxes declined to $4.1 million in Q1 2026, from $12.0 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $12.0 million in Q4 2025 to a low of -$63.0 million in Q2 2023.
• A 5-year average of -$5.2 million and a median of -$160500.0 in 2022 frame the typical range for Deferred Taxes.
• Peak annual rise in Deferred Taxes reached 2459.49% in 2023, while the deepest fall reached 108746.55% in 2023.
• Tracing GDRX's Deferred Taxes over 5 years: stood at -$356000.0 in 2022, then sank by 2027.25% to -$7.6 million in 2023, then slumped by 48.84% to -$11.3 million in 2024, then surged by 206.3% to $12.0 million in 2025, then slumped by 66.04% to $4.1 million in 2026.
• Business Quant data shows GDRX's Deferred Taxes at $4.1 million in Q1 2026, $12.0 million in Q4 2025, and -$11.3 million in Q4 2024.